Bespoke, Inc.

SAN FRANCISCO, CA · CIK 0001852229 · Biotech

Cell-free enzyme mix for DNA amplification without bacterial culture

bespoke.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$14M
2 Form D · Nov 2022
46 months since last filing
Contracts
—
No federal contracts on record
Patents
1
1 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$14,000,000
Private capital raisedForm D · SEC$454,613
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2064General Probiotics Inc——
2065PNEUMOTACTIX, LLC——
2066VIRVIO, INC.——
2067Bespoke, Inc.—$14M
2068D BioTherapeutics, LLC——
2069Isomorphic Labs——
2070Courier Therapeutics Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Antoine AmielDirector
  • George SchaefferDirector
  • Michael TolentinoDirector
  • Eric VaradyDirector · Executive Officer
  • Rob VaradyExecutive Officer

Patents

USPTO · 1 granted of 1

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.